Zealand Pharma A/S Ord
(ZLDPF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 9,090 | 49,773 | 14,724 | 46,547 | 54,128 |
| Cost of Goods | 1,142 | 2,784 | N/A | 18,903 | 13,875 |
| Gross Profit | 7,949 | 46,989 | 14,724 | 27,644 | 40,253 |
| Operating Expenses | 192,560 | 130,862 | 133,265 | 195,980 | 162,517 |
| Operating Income | -184,470 | -83,089 | -118,541 | -167,432 | -121,390 |
| Interest Expense | 7,468 | 27,696 | 37,971 | 2,511 | 7,555 |
| Other Income | 34,838 | 7,858 | 18,871 | 6,557 | 310 |
| Pre-tax Income | -157,100 | -102,927 | -137,641 | -163,386 | -128,635 |
| Income Tax | -670 | -744 | -911 | -1,399 | 1,084 |
| Net Income Continuous | -156,430 | -102,183 | -136,730 | -161,988 | -129,719 |
| Net Income Discontinuous | N/A | N/A | -33,492 | N/A | N/A |
| Net Income | $-156,430 | $-102,183 | $-170,222 | $-161,988 | $-129,719 |
| EPS Basic Total Ops | -2.35 | -1.81 | -3.68 | -3.78 | -3.38 |
| EPS Basic Continuous Ops | -2.35 | -1.81 | -2.96 | -3.78 | -3.38 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.72 | N/A | N/A |
| EPS Diluted Total Ops | -2.35 | -1.81 | -3.68 | -3.78 | -3.38 |
| EPS Diluted Continuous Ops | -2.35 | -1.81 | -2.96 | -3.78 | -3.38 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.72 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.36 | -1.81 | -2.95 | -3.78 | -3.38 |
| EBITDA(a) | $-180,722 | $-79,447 | $-101,838 | $-161,029 | $-114,849 |